Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Hypertension Reports|May 6, 2026
Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?Dominik Kylies, Leonie Dreher, Ulrich O Wenzel
American Journal of Physiology. Heart and Circulatory Physiology|February 28, 2025
Aortic aneurysm and dissection: complement and precision medicine in aortic diseaseLeonie Dreher, Malte B Kuehl, Ulrich O Wenzel, et al.
Hypertension (Dallas, Tex. : 1979)|May 23, 2025
Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management?Leonie Dreher, Dominik Kylies, A H Jan Danser, et al.
Clinical Kidney Journal|June 9, 2025
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathyLeonie Dreher, Lars Nilges, Thorsten Wiech, et al.
American Journal of Hypertension|June 27, 2024
Role of the Anaphylatoxin Receptor C5aR2 in Angiotensin II-Induced Hypertension and Hypertensive End-Organ DamageLeonie Dreher, Marlies Bode, Nicolas Ehnert, et al.
Frontiers in Immunology|July 1, 2026
Association of the inflammatory marker suPAR with chronic pruritus of unknown origin - data from the SOMA.PRU studyStefan M Kahnert, Lara Jürgens, Leonie Dreher, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2023
Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ DamageMarlies Bode, Georg R Herrnstadt, Leonie Dreher, et al.
Pageof 1